-
EC eCQMs - Eligible Clinicians
-
Resolution: Answered
-
Moderate
-
None
-
None
-
-
CMS0002v11
-
Not sure if the Strep test "within 3 days" includes both before AND after Pharyngitis encounter end. Need clarification for 2022 configuration guidance.
While reviewing the espec for CMS 146 version 10 Numerator for 2022, we noticed the wording had changed slightly from last year:
2021
from
"Group A Streptococcus Lab Test With Result" GroupAStreptococcusTest,
"Encounter With Pharyngitis or Tonsillitis" EncounterWithPharyngitis
where ( GroupAStreptococcusTest.relevantDatetime 3 days or less on or before day of
end of EncounterWithPharyngitis.VisitWithAntibiotic.relevantPeriod
or GroupAStreptococcusTest.relevantDatetime 3 days or less on or after day of
end of EncounterWithPharyngitis.VisitWithAntibiotic.relevantPeriod
)
return EncounterWithPharyngitis.VisitWithAntibiotic
**2022 **
from
"Group A Streptococcus Lab Test With Result" GroupAStreptococcusTest,
"Encounter With Pharyngitis or Tonsillitis With Antibiotic" EncounterWithPharyngitis
where ( Global."NormalizeInterval" ( GroupAStreptococcusTest.relevantDatetime, GroupAStreptococcusTest.relevantPeriod ) starts within 3 days of
end of EncounterWithPharyngitis.relevantPeriod
)
return EncounterWithPharyngitis
We wanted to clarify and confirm that the wording means the same thing from 2021 year to 2022 year and that the configuration should not change here as far as that highlighted timing value goes.
Please clarify and confirm. Thank you for your help in advance.